||**Utopia Theatre**|**Utopia Theatre**|**Utopia Theatre**|**1192008**|**1192008**|**CC16a**|
|---|---|---|---|---|---|---|
||**For the period**<br>**from**|01/07/2021|**To**|30/06/2022|||
||||||||
|**Section A Receipts and payments**|||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**87**<br>**15,433**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,520**<br>**-**<br>**-**<br>**-**<br>**15,520**<br>**1,000**<br>**377**<br>**0**<br>**207**<br>**1,795**<br>**1,708**<br> **5,087**<br>**-**<br>**-**<br> **-**<br>**5,087**<br>**10,433**<br>**-**<br>**9**<br>**10,442**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**87**<br>**-**<br>**15,433**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,520**<br>**-**<br>**-**<br>**-**<br>**15,520**<br>**1,000**<br>**377**<br>**0**<br>**207**<br>**1,795**<br>**1,708**<br>**-**<br>**-**<br>**-**<br>**5,087**<br>**-**<br>**-**<br>**-**<br>**5,087**<br> <br>**10,433**||**Last year**<br>**to the nearest £**|
|JustGiving|**87**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**87**||**2,080**|
|Donations via PayPal||||**-**||**218**|
|Grants receivable|**15,433**|||**15,433**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**15,520**|||**15,520**||**2,298**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**||**-**|
|**_Sub total_**|**-**|||**-**||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
||||**-**|**15,520**||**2,298**|
||||||||
|Baobabproject|**1,000**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**1,000**||**2,080**|
|Overheads|**377**|||**377**||**209**|
|Bank charges|**0**|||**0**||**-**|
|Consultancyfees|**207**|||**207**||**-**|
|Covid relief|**1,795**|||**1,795**||**-**|
|Anna Hibiscus R & D|**1,708**|||**1,708**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|||||**-**||**-**|
|**_Sub total_ **|**5,087**|||**5,087**||**2,289**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**|||
|**_Sub total_ **|**-**|||**-**||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
||||**-**|**5,087**||**2,289**|
||||||||
||**10,433**|**-**|**-**|<br>**10,433**||**9**|
||**-**|**-**|**-**<br>**-**|**-**||**-**|
||**9**|**-**||**9**||**-**|
||**10,442**|**-**|**-**|**10,442**||**9**|



CCXX R1 accounts (SS) 

17/03/2023 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**|**Details**<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>Bank account<br>**Details**<br>Signature<br>Mojisola ELUFOWJU|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**10,442**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**10,442**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Mojisola ELUFOWJU|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**9**|
||||**-**|
||||**-**|
||||**9**|
||||Agreement Error|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||Mojisola ELUFOWJU|Mojisola ELUFOWJU|20/03/2023|
|||||



CCXX R2 accounts (SS) 

17/03/2023 

2 

